跳转至内容
Merck
CN
  • Reversible promoter methylation determines fluctuating expression of acute phase proteins.

Reversible promoter methylation determines fluctuating expression of acute phase proteins.

eLife (2020-04-01)
Shi-Chao Zhang, Ming-Yu Wang, Jun-Rui Feng, Yue Chang, Shang-Rong Ji, Yi Wu
摘要

Acute phase reactants (APRs) are secretory proteins exhibiting large expression changes in response to proinflammatory cytokines. Here we show that the expression pattern of a major human APR, that is C-reactive protein (CRP), is casually determined by DNMT3A and TET2-tuned promoter methylation status. CRP features a CpG-poor promoter with its CpG motifs located in binding sites of STAT3, C/EBP-β and NF-κB. These motifs are highly methylated at the resting state, but undergo STAT3- and NF-κB-dependent demethylation upon cytokine stimulation, leading to markedly enhanced recruitment of C/EBP-β that boosts CRP expression. Withdrawal of cytokines, by contrast, results in a rapid recovery of promoter methylation and termination of CRP induction. Further analysis suggests that reversible methylation also regulates the expression of highly inducible genes carrying CpG-poor promoters with APRs as representatives. Therefore, these CpG-poor promoters may evolve CpG-containing TF binding sites to harness dynamic methylation for prompt and reversible responses.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
Chelex ® 100 钠形式, 50-100 mesh (dry)
Sigma-Aldrich
Eagle最低必需培养基, With Earle′s salts, L-glutamine, and non-essential amino acids, without sodium bicarbonate, powder, suitable for cell culture
Sigma-Aldrich
5-阿扎胞苷, ≥98% (HPLC)
Sigma-Aldrich
RG108, ≥98% (HPLC), powder
Sigma-Aldrich
Ribonuclease Inhibitor, Human, Recombinant, E. coli, The Ribonuclease Inhibitor, Human, Recombinant, E. coli controls the biological activity of Ribonuclease. This small molecule/inhibitor is primarily used for Protease Inhibitors applications.